Skip to main content

Table 4 Pharmacokinetic study of ELX using the proposed method

From: Ultra-sensitive and selective fluorescence approach for estimation of elagolix in real human plasma and content uniformity using boron-doped carbon quantum dots

Time (h)

Oral (ng mL−1)

Parameters

Results

0.5

320

Cmax (ng mL−1)

570 ± 5.32

1.0

570

Tmax (h)

1.0 ± 0.10

3.0

500

t ½ (h)

6.5 ± 1.01

5.0

400

AUC (ng·h mL−1)

1290 ± 30.33

6

280

  

9

200

  

10

100

  

15

70

  

20

50

  

25

42

  

30

20